People in brief | Maxwellia, Bayer, AFT
13 January 2021
Maxwellia has appointed a finance director, Bayer has recruited a chief transformation and talent officer, and AFT Pharmaceuticals has gained expertise in North America.
Industry News - Tag: AFT
You can read our Premium News Service in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.
AFT opens European office and signs new deals
Premium
24 November 2020
New Zealand’s AFT Pharmaceuticals has opened a European office and signed up distribution partners for the oral tablet version of its Maxigesic combination painkiller in Greece, Pakistan and Ecuador.
Industry in brief | Alcon, Karo, Venture Life, AFT
21 July 2020
Alcon is extending its Pataday OTC range in the US, Karo Pharma and Venture Life have released financial results, while AFT Pharmaceuticals is working with RooLife Group to launch an online health and pharmacy store in China.
New Zealand’s AFT Pharmaceuticals raises funds
Premium
19 June 2020
AFT Pharmaceuticals, owner of the Maxigesic combination painkiller, has raised around NZD10 million (USD6.47 million) through issuing new shares. The New Zealand-based company said the move would “increase liquidity and reduce debt”.
AFT sees demand and challenges amid COVID-19
Premium
25 March 2020
New Zealand’s AFT Pharmaceuticals says it is experiencing strong demand for a number of its products, including Maxigesic and Vitamin C Lipo-Sachets, due to the COVID-19 pandemic.
AFT agrees four new licensing deals for Maxigesic
Premium
27 November 2019
AFT Pharmaceuticals is set to launch Maxigesic/Combogesic in Canada through a licensing deal with local firm BioSyent Pharma. The New Zealand company has also recently agreed deals for the combination pain reliever in Germany, Pakistan and Vietnam.
AFT works with SETEK on medicinal cannabis
Premium
14 October 2019
AFT Pharmaceuticals is joining forces with fellow New Zealand company SETEK to develop medicinal cannabis products.